BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31669248)

  • 1. Role of HLA-B exon 1 in graft-versus-host disease after unrelated haemopoietic cell transplantation: a retrospective cohort study.
    Petersdorf EW; Carrington M; O'hUigin C; Bengtsson M; De Santis D; Dubois V; Gooley T; Horowitz M; Hsu K; Madrigal JA; Maiers MJ; Malkki M; McKallor C; Morishima Y; Oudshoorn M; Spellman SR; Villard J; Stevenson P;
    Lancet Haematol; 2020 Jan; 7(1):e50-e60. PubMed ID: 31669248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-B leader and survivorship after HLA-mismatched unrelated donor transplantation.
    Petersdorf EW; Stevenson P; Bengtsson M; De Santis D; Dubois V; Gooley T; Horowitz M; Hsu K; Madrigal JA; Malkki M; McKallor C; Morishima Y; Oudshoorn M; Spellman SR; Villard J; Carrington M
    Blood; 2020 Jul; 136(3):362-369. PubMed ID: 32483623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of HLA-DP Expression in Graft-Versus-Host Disease After Unrelated Donor Transplantation.
    Petersdorf EW; Bengtsson M; De Santis D; Dubois V; Fleischhauer K; Gooley T; Horowitz M; Madrigal JA; Malkki M; McKallor C; Morishima Y; Oudshoorn M; Spellman SR; Villard J; Stevenson P; Carrington M; ;
    J Clin Oncol; 2020 Aug; 38(24):2712-2718. PubMed ID: 32479188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study.
    Fleischhauer K; Shaw BE; Gooley T; Malkki M; Bardy P; Bignon JD; Dubois V; Horowitz MM; Madrigal JA; Morishima Y; Oudshoorn M; Ringden O; Spellman S; Velardi A; Zino E; Petersdorf EW;
    Lancet Oncol; 2012 Apr; 13(4):366-74. PubMed ID: 22340965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide minor histocompatibility matching as related to the risk of graft-versus-host disease.
    Martin PJ; Levine DM; Storer BE; Warren EH; Zheng X; Nelson SC; Smith AG; Mortensen BK; Hansen JA
    Blood; 2017 Feb; 129(6):791-798. PubMed ID: 27872059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation.
    Woolfrey A; Klein JP; Haagenson M; Spellman S; Petersdorf E; Oudshoorn M; Gajewski J; Hale GA; Horan J; Battiwalla M; Marino SR; Setterholm M; Ringden O; Hurley C; Flomenberg N; Anasetti C; Fernandez-Vina M; Lee SJ
    Biol Blood Marrow Transplant; 2011 Jun; 17(6):885-92. PubMed ID: 20870028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
    Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
    PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the HLA-B leader to optimize cord blood transplantation.
    Petersdorf EW; Gooley T; Volt F; Kenzey C; Madrigal A; McKallor C; Querol S; Rafii H; Rocha V; Tamouza R; Chabannon C; Ruggeri A; Gluckman E
    Haematologica; 2021 Dec; 106(12):3107-3114. PubMed ID: 33121238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation.
    Spierings E; Kim YH; Hendriks M; Borst E; Sergeant R; Canossi A; Oudshoorn M; Loiseau P; Dolstra H; Markiewicz M; Leffell MS; Pereira N; Kircher B; Turpeinen H; Eliaou JF; Gervais T; Laurin D; Enczmann J; Martinetti M; Thomson J; Oguz F; Santarone S; Partanen J; Siekiera U; Alessandrino EP; Kalayoglu S; Brand R; Goulmy E
    Biol Blood Marrow Transplant; 2013 Aug; 19(8):1244-53. PubMed ID: 23756210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High HLA-DP Expression and Graft-versus-Host Disease.
    Petersdorf EW; Malkki M; O'hUigin C; Carrington M; Gooley T; Haagenson MD; Horowitz MM; Spellman SR; Wang T; Stevenson P
    N Engl J Med; 2015 Aug; 373(7):599-609. PubMed ID: 26267621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis.
    Shouval R; Fein JA; Labopin M; Kröger N; Duarte RF; Bader P; Chabannon C; Kuball J; Basak GW; Dufour C; Galimard JE; Polge E; Lankester A; Montoto S; Snowden JA; Styczynski J; Yakoub-Agha I; Mohty M; Nagler A
    Lancet Haematol; 2019 Nov; 6(11):e573-e584. PubMed ID: 31477550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of haematopoietic stem cell transplantation in patients transplanted with matched unrelated donors vs allele-mismatched donors: a single centre study.
    Hauzenberger D; Schaffer M; Ringdén O; Hassan Z; Omazic B; Mattsson J; Wikström AC; Remberger M
    Tissue Antigens; 2008 Dec; 72(6):549-58. PubMed ID: 19000143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide.
    Fuchs EJ; McCurdy SR; Solomon SR; Wang T; Herr MR; Modi D; Grunwald MR; Nishihori T; Kuxhausen M; Fingerson S; McKallor C; Bashey A; Kasamon YL; Bolon YT; Saad A; McGuirk J; Paczesny S; Gadalla SM; Marsh SGE; Shaw BE; Spellman SR; Lee SJ; Petersdorf EW
    Blood; 2022 Mar; 139(10):1452-1468. PubMed ID: 34724567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I study of graft-versus-host disease prophylaxis including bortezomib for allogeneic hematopoietic cell transplantation from unrelated donors with one or two HLA loci mismatches in Japanese patients.
    Nakane T; Okamura H; Tagaito Y; Koh S; Yoshimura T; Makuuchi Y; Nanno S; Nakamae M; Hirose A; Nakashima Y; Koh H; Hino M; Nakamae H
    Int J Hematol; 2019 Dec; 110(6):736-742. PubMed ID: 31560116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human leukocyte antigen supertype matching after myeloablative hematopoietic cell transplantation with 7/8 matched unrelated donor allografts: a report from the Center for International Blood and Marrow Transplant Research.
    Lazaryan A; Wang T; Spellman SR; Wang HL; Pidala J; Nishihori T; Askar M; Olsson R; Oudshoorn M; Abdel-Azim H; Yong A; Gandhi M; Dandoy C; Savani B; Hale G; Page K; Bitan M; Reshef R; Drobyski W; Marsh SG; Schultz K; Müller CR; Fernandez-Viña MA; Verneris MR; Horowitz MM; Arora M; Weisdorf DJ; Lee SJ
    Haematologica; 2016 Oct; 101(10):1267-1274. PubMed ID: 27247320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-resolution HLA matching in hematopoietic stem cell transplantation: a retrospective collaborative analysis.
    Fürst D; Müller C; Vucinic V; Bunjes D; Herr W; Gramatzki M; Schwerdtfeger R; Arnold R; Einsele H; Wulf G; Pfreundschuh M; Glass B; Schrezenmeier H; Schwarz K; Mytilineos J
    Blood; 2013 Oct; 122(18):3220-9. PubMed ID: 24046013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrolimus does not abrogate the increased risk of acute graft-versus-host disease after unrelated-donor marrow transplantation with allelic mismatching at HLA-DRB1 and HLA-DQB1.
    Przepiorka D; Saliba R; Cleary K; Fischer H; Tonai R; Fritsche H; Khouri IF; Folloder J; Ueno NT; Mehra R; Ippoliti C; Giralt S; Gajewski J; Donato M; Claxton D; Braunschweig I; van Besien K; Anderlini P; Andersson BS; Champlin R
    Biol Blood Marrow Transplant; 2000; 6(2A):190-7. PubMed ID: 10816027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.
    Farag SS; Bacigalupo A; Eapen M; Hurley C; Dupont B; Caligiuri MA; Boudreau C; Nelson G; Oudshoorn M; van Rood J; Velardi A; Maiers M; Setterholm M; Confer D; Posch PE; Anasetti C; Kamani N; Miller JS; Weisdorf D; Davies SM;
    Biol Blood Marrow Transplant; 2006 Aug; 12(8):876-84. PubMed ID: 16864058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sibling versus unrelated donor allogeneic hematopoietic cell transplantation for chronic myelogenous leukemia: refined HLA matching reveals more graft-versus-host disease but not less relapse.
    Weisdorf DJ; Nelson G; Lee SJ; Haagenson M; Spellman S; Antin JH; Bolwell B; Cahn JY; Cervantes F; Copelan E; Gale R; Gratwohl A; Khoury HJ; McCarthy P; Marks DI; Szer J; Woolfrey A; Cortes-Franco J; Horowitz MM; Arora M;
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1475-8. PubMed ID: 19822308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MHC haplotype matching for unrelated hematopoietic cell transplantation.
    Petersdorf EW; Malkki M; Gooley TA; Martin PJ; Guo Z
    PLoS Med; 2007 Jan; 4(1):e8. PubMed ID: 17378697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.